Month: February 2024

Bolstering the Leadership Team The Global Library of Medicine Passes Milestone of 1000+ Diseases       Treatment Provides Platform to Support Healthcare in Nairobi, KenyaVANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working diligently to continue its acceleration into the US market. A few key milestones the Company has accomplished are as follows: Bolstering the Leadership Team Dr. Essam Hamza, MD – Appointed Chief Executive Officer & Director The appointment of Dr. Hamza follows a mandate to appoint a leader with a rare combination of extensive healthcare, technology and capital markets experience capable of leading the Company through...

ATCHISON, Kan., Feb. 29, 2024 (GLOBE NEWSWIRE) — MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider of distilled spirits, branded spirits, and food ingredient solutions, today announced that its board of directors has approved the repurchase of up to $100.0 million of the Company’s outstanding shares of common stock. “Following another record year and strong results from each of our three business segments in 2023, we are well positioned to implement this additional pillar of shareholder return while maintaining a strong balance sheet to enable additional growth opportunities,” said David Bratcher, CEO and president of MGP Ingredients. “Today’s announcement reflects our continued confidence in our strategy, the sustainable strength of our business, and our ability to generate strong, long-term cash flows.” The Company may...

AUSTIN, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), a leading artificial intelligence (AI) travel technology company and marketplace with a portfolio of global platforms in the leisure and corporate travel sectors, announced that it will report fourth quarter and full year 2023 financial results for the period ended December 31, 2023, on Thursday, March 14, 2024 via an earnings release and accompanying webcast. The Company will host the live audio webcast at 5:30 a.m. (PT) / 7:30 a.m. (CT) / 8:30 a.m. (ET) on Thursday, March 14, 2024, to discuss its financial results with the investment community. The webcast is expected to last approximately one hour and will be accessible by visiting the Mondee Investor Relations website at https://investors.mondee.com. A live dial-in...

AUSTIN, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), a leading artificial intelligence (AI) travel technology company and marketplace with a portfolio of global platforms in the leisure and corporate travel sectors, announced that Executive Vice Chairman Orestes Fintiklis, Chief Operating Officer Jim Dullum, and SVP Jeff Houston will present and host one-on-one meetings at the following investor and industry conferences. The Citizens JMP Technology Conference, San Francisco, CADate: March 5th, 2024Presentation: 2:00 p.m. ETWebcast Link: https://wsw.com/webcast/jmp62/mond/1675730 PANROTAS Forum, Sao Paulo, BrazilDate: March 5th, 2024 Morgan Stanley Technology, Media & Telecom Conference, San Francisco, CADate: March 6th and 7th, 2024 36th Annual ROTH Conference, Dana...

Proof-of-concept (PoC) human clinical trial targeting multi-billion-dollar pancreatic cancer market through transvascular RF ablation Agreements represent final steps needed in order to commence patient enrollment, expected imminently THE WOODLANDS, TX, Feb. 29, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced it has entered into a clinical site agreement with “АКFА MEDLINE” Ltd., for its PoC human clinical trial evaluating the use of transvascular RF ablation for the treatment of pancreatic cancer pain. Additionally, Autonomix announced the selection of Clinical Accelerator and Qmed, full service Clinical Research...

The Company Will Host a Conference Call on Thursday, March 14, 2024, at 08:30 a.m. Eastern Time Tel Aviv, Israel, Feb. 29, 2024 (GLOBE NEWSWIRE) —  Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, will release its financial results for the fourth quarter and full year 2023, on March 14, 2024, before the Nasdaq market opens, on Thursday March 14, 2024. Mr. Shachar Daniel, Chief Executive Officer, and Mr. Shai Avnit, Chief Financial Officer, will host a conference call on March 14, 2024, at 8:30 a.m. Eastern Time, to discuss the financial results, followed by a Q&A session. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your call five minutes before the conference...

– Slacker Radio Added Another 50,000 Memberships in February. Memberships Now Exceed 3.6M with 760,000 New Members Added Year-Over-Year. Memberships have Grown over 800% Since Acquisition – Slacker Radio Revenue has Increased 225% Since Acquiring from $20M to over $65M in Fiscal Year 2024 ending March 31st, 2024 – Slacker Radio Adjusted EBITDA is on Pace for $15M in Fiscal Year 2024 Compared to Losing $10M Prior to Acquisition – Increases Current Pipeline to Over 50 Potential B2B Partnerships as Slacker Radio’s Lean Back Experience Utilizing AI Technology Continues to Resonate with Fortune 500 Companies LOS ANGELES, CA, Feb. 29, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — LiveOne (Nasdaq: LVO) About LiveOne, Inc. LiveOne, Inc. is an award-winning, creator-first, music, entertainment, and technology...